Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$31.65 +0.25 (+0.80%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Asset Writedowns and Impairment (2025)

Updated

Lakefront Biotherapeutics' Asset Writedowns and Impairment came in at $1.28 million for the year ended Dec 31, 2018.

Analysis

Lakefront Biotherapeutics (LKFT) Asset Writedowns and Impairment (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Lakefront Biotherapeutics 2.09 Bn 2.09 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 503.87 Mn
API Access

Lakefront Biotherapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=LKFT&period=max&api_key=YOUR_API_KEY